首页> 美国政府科技报告 >Biomarkers for Early Detection of Clinically Relevant Prostate Cancer. A Multi-Institutional Validation Trial.

【24h】

Biomarkers for Early Detection of Clinically Relevant Prostate Cancer. A Multi-Institutional Validation Trial.

机译：用于早期检测临床相关前列腺癌的生物标志物。多机构验证试验。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
McKenney, J.;
展开▼
作者单位

展开▼
年度 2016
页码 1-49
总页数 49
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Epigenetic events highlight the challenge of validating prognostic biomarkers during the clinical and biologic evolution of prostate cancer. [J] . Febbo PG Journal of Clinical Oncology . 2009,第19期

机译：表观遗传事件突出了在前列腺癌的临床和生物学进化过程中验证预后生物标志物的挑战。
2. Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network [J] . Andrée-Anne Grosset, Véronique Ouellet, Christine Caron, PLoS Medicine . 2019,第7期

机译：NF-κBp65在前列腺癌中的预后价值的验证：一项使用加拿大前列腺癌生物标志物网络的大型多机构队列的回顾性研究
3. In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice [J] . Amalia Katafigioti, Ioannis Katafigiotis, Stavros Sfoungaristos, Archivio Italiano di Urologia e Andrologia . 2016,第3期

机译：在寻找用于前列腺癌的早期诊断的新型尿液生物标志物。细胞内或分泌蛋白作为目标人群？在哪里以及如何搜索可能在日常临床实践中有用的生物标记
4. AN INTEGRATED FRAMEWORK FOR REPORTING CLINICALLY RELEVANT BIOMARKERS FROM PAIRED TUMOR/NORMAL GENOMIC AND TRANSCRIPTOMIC SEQUENCING DATA IN SUPPORT OF CLINICAL TRIALS IN PERSONALIZED MEDICINE [C] . SARA NASSER, AHMET A. KURDOLGU, TYLER IZATT, Pacific Symposium on Biocomputing . 2015

机译：一种综合框架，用于报告来自配对肿瘤/正常基因组和转录组序列测序数据的临床相关的生物标志物，以支持个性化医学中的临床试验
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network [O] . Andrée-Anne Grosset, Véronique Ouellet, Christine Caron, 2019

机译：NF-κBp65在前列腺癌中的预后价值的验证：一项使用加拿大前列腺癌生物标志物网络的大型多机构队列的回顾性研究
7. Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network [O] . Andrée-Anne Grosset, Véronique Ouellet, Christine Caron, 2019

机译：NF-κBP65在前列腺癌中的预后价值验证：一种利用加拿大前列腺癌生物标志网络的大型多机构队列的回顾性研究
8. Biomarkers for Early Detection of Clinically Relevant Prostate Cancer: A Multi-Institutional Validation Trial. [R] . Lin, D. 2017

机译：用于早期检测临床相关前列腺癌的生物标志物：多机构验证试验。

Biomarkers for Early Detection of Clinically Relevant Prostate Cancer. A Multi-Institutional Validation Trial.

著录项

引文网络

相似文献

相关主题

期刊订阅